• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – The Cannabis and Psychedelics sectors remain in a state of flux, balancing regulatory progress, market milestones, and corporate maneuvers with persistent challenges. Mature markets posted impressive revenue numbers, major operators strengthened their ...

Ascend Wellness Reports Q4 and FY 2025 Financial Results

NEW YORK – Ascend Wellness Holdings Inc. released its fourth-quarter and full-year 2025 earnings, underscoring a calculated shift among MSOs toward operational and margin discipline in response to persistent industry challenges. The disclosure illustrates how ...

Village Farms Reports Q4 and FY 2025 Financial Results

VANCOUVER – Village Farms International, Inc. released earnings demonstrating a significant operational turnaround – the result of deliberate strategies focused on enhancing production efficiencies, expanding global export channels, and optimizing product mix in its Cannabis ...

TerrAscend Reports Q4 and FY 2025 Financial Results

TORONTO – In an industry still wrestling with persistent pricing compression, TerrAscend Corp. managed to hold the line on profitability while posting modest sequential growth in its latest quarter. The company released its financial results, ...

New Mexico Sets Record in Cannabis Sales for March

LOS ANGELES- In a significant development within the cannabis industry, New Mexico reported a record-breaking total of over $52 million in combined recreational and medical cannabis sales for March. This figure surpasses previous records, marking ...

Hawaii’s Adult-Use Cannabis Legalization Stalls

LOS ANGELES- In a recent development within Hawaii's legislative process, a pivotal House committee announced it will not advance a bill proposing the legalization and regulation of recreational cannabis, effectively halting the legislation for 2024. ...

DEA to Conduct Hearing on Psychedelic Substances Proposal

LOS ANGELES- The Drug Enforcement Administration (DEA) has announced plans to hold a hearing regarding the proposed classification of two psychedelic substances, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC), as Schedule I drugs under the Controlled Substances ...

Alabama Seeks to Expand Medical Cannabis Licensing

LOS ANGELES- In an effort to resolve ongoing legal disputes surrounding its medical cannabis licensing process, Alabama has introduced a bill proposing an increase in the number of available licenses. Filed on Tuesday, the legislation ...

Oregon Reinstates Criminal Penalties for Drug Possession

LOS ANGELES- In a landmark reversal, Oregon Governor Tina Kotek has endorsed House Bill 4002, reintroducing criminal penalties for possession of controlled substances such as fentanyl, heroin, and methamphetamine. This action marks a departure from ...

Alberta Leads in Psychedelic-Assisted Therapy Coverage

NEW YORK- Alberta Blue Cross's recent endorsement of insurance coverage for Psychedelic-Assisted Therapy signifies a pioneering move in Canadian healthcare, positioning Alberta as the first province to officially support and regulate such treatments. This development ...

Subscribe To Our Newsletter

Go to Top